PEBC PEBC Drug Dispensing and Compounding

Question 1

When a pharmacist receives a prescription for a controlled substance in Canada, which document must be retained for a minimum of two years?

Accepted Answer

The original prescription

Answer

Original prescriptions for controlled substances must be retained for a minimum of two years as required by Canadian federal regulations.

Question 2

Which beyond-use date (BUD) applies to a non-sterile compounded preparation stored at room temperature according to USP <795> guidelines used in PEBC practice?

Accepted Answer

35 days

Answer

USP <795> assigns a default BUD of 35 days for non-sterile solid and non-aqueous liquid preparations stored at controlled room temperature.

Question 3

A pharmacist is compounding a topical cream for a patient. Which of the following is the most critical step before compounding begins?

Accepted Answer

Verifying the formulation is appropriate and checking for ingredient compatibility

Answer

Verifying formulation appropriateness and ingredient compatibility is paramount to ensure patient safety before any compounding activity.

Question 4

Under the NAPRA Model Standards, which class of pharmacy compounding involves preparing commercially unavailable products requiring specialized technique?

Accepted Answer

Category B

Answer

Category B compounding under NAPRA standards covers preparations that are commercially unavailable and require more complex techniques and quality controls.

Question 5

When dispensing a narrow therapeutic index (NTI) drug like warfarin, what is the pharmacist's primary responsibility at dispensing?

Accepted Answer

Providing counselling on dose, adherence, and signs of adverse effects

Answer

For NTI drugs, pharmacist counselling on dosing, adherence, and adverse effect monitoring is critical because small variations can lead to serious harm.

PEBC - Pharmacy Examining Board of Canada Practice Test

PEBC - Pharmacy Examining Board of Canada Practice Test

PEBC PEBC Drug Dispensing and Compounding